查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1912827

真空采血管市场：按产品类型、采血系统、添加剂、容量、应用和最终用户划分－2026-2032年全球预测

Vacutainer Blood Collection Tube Market by Product Type, Blood Collection System, Additive, Volume, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年真空采血管市场价值为 16.4 亿美元，预计到 2026 年将成长至 17.4 亿美元，年复合成长率为 6.75%，到 2032 年将达到 26 亿美元。

关键市场统计数据
基准年 2025 16.4亿美元
预计年份：2026年 17.4亿美元
预测年份 2032 26亿美元
复合年增长率 (%) 6.75%

一份策略性主管概述，涵盖了影响真空采血管产业的基本驱动因素、临床意义、材料创新和采购考量。

本执行摘要为采购主管、临床实验室主任、生产负责人和投资者提供了一份简洁专业的Vacutainer采血管市场概览。它整合了市场动态、材料和设计趋势、供应链脆弱性以及临床应用驱动因素，同时保持了决策者所需的实用性。摘要重点强调了材料选择、系统人体工学、辅料相容性和最终用户工作流程等影响采购和产品开发决策的核心因素。

识别关键的转型转变，这些转变正在重新定义真空采血管市场的产品设计、供应链韧性、添加剂标准化以及对临床工作流程的影响。

真空采血管生态系统正经历多重变革，这些变革正在改变产品设计、筹资策略和临床实践。材料创新是其核心，玻璃和先进塑胶之间的过渡反映了检体完整性、破损风险和成本效益之间相互衝突的考虑。同时，真空密封技术和管盖系统的改进降低了溶血率，提高了高灵敏度检测的检体稳定性，从而影响了临床医生和检查室的选择。

分析2025年美国关税调整对真空包装产品筹资策略、生产基地、采购行为及供应链韧性的累积影响

2025年美国生效的关税调整将对真空包装供应链上的所有相关人员产生复杂而多方面的影响。关税变化可能会增加进口原材料和成品的到岸成本，促使采购团队重新评估总拥有成本并探索替代筹资策略。如果进口关税影响到玻璃组件、聚合物树脂或辅助包装材料，製造商可能会转移生产地点或重新谈判供应商合同，以保持竞争力并维持品质标准。

全面的細項分析揭示了产品类型、采血系统、辅料化学成分、临床应用、终端用户需求和试管容量如何影响需求和采购决策。

详细的細項分析揭示了产品类型、采集系统、赋形剂、应用、最终用户和销售等因素对需求驱动因素的细微差别，从而指南产品策略和市场推广策略。就产品类型而言，在化学惰性和高温灭菌是优先考虑因素的场合，玻璃仍然是首选；但塑料因其抗碎裂性、轻便性和扩充性的生产方式而日益普及。就采集系统而言，蝶形针对于困难采血和儿童护理至关重要；注射器用于某些床边和介入医学场景；而真空采血管因其高效性和与自动化处理的兼容性，在常规检查室工作流程中占据主导地位。

区域洞察：美洲、欧洲、中东和非洲以及亚太地区对真空采血管产品製造地选择、监管协调和分销策略的影响

区域趋势将在决定真空采血管产品的製造地、监管路径和分销策略方面发挥关键作用。在美洲，大规模综合医疗保健网路、完善的血库基础设施和先进的实验室自动化技术影响市场需求，供应商则专注于规模、文件和服务协议。欧洲、中东和非洲地区的情况则呈现出多样性：在欧洲部分地区，严格的管理体制和对可追溯性的重视推动了合规性投资，而中东和北非地区的市场则在物流能力波动的情况下，优先考虑可靠且经济高效的供应。

关键公司和竞争考察，概述了真空采血管市场领导者与挑战者在创新、製造地、监管严格程度和策略伙伴关係关係方面的差异。

竞争格局呈现出成熟製造商、专业利基生产商和契约製造製造商并存的局面，它们都在推动创新、规模化和分销。市场领导往往透过投资材料科学、高通量生产和完善的品质系统来脱颖而出，这些系统能够支持全球监管申报。专业公司则经常推出针对特定临床领域或高价值终端用户的创新产品，例如低溶血性瓶盖、用于新型检测的赋形剂优化以及符合人体工学的采血系统，从而展开竞争。

针对製造商、经销商和负责人的具体策略建议：加强创新通路建设、实现采购多元化以及加强临床和商业合作

为了获得可持续的竞争优势，产业领导者应采取多管齐下的策略，平衡材料创新、供应链韧性以及与临床工作流程的紧密结合。优先进行材料和辅料的研发，以证明其能够提高检体完整性并降低分析前变异性，并在临床化学和血液学等常见临床应用中检验这些改进。同时，应实现生产和采购多元化，并引入区域合作伙伴，以降低关税相关风险，并在不断变化的贸易环境中缩短补货週期。

本文概述了透明严谨的调查方法，描述了关键相关人员的参与、二次检验、数据三角测量以及分析中应用的品管措施。

分析采用混合研究方法，结合了实验室主任、采购人员、生产工程师和临床科学家的访谈，以及对监管文件、生产标准和产品文献的全面二次检验。一手研究包括结构化访谈和专题研讨会，旨在揭示采购挑战、辅料偏好和自动化相容性问题。二级资讯来源则用于检验监管路径、材料性能声明和已发布的生产规范指南。

综合策略要务，协调真空包装领域的材料创新、供应链敏捷性、监管准备和终端用户合作。

总之，真空采血管生态系统处于不断发展的材料科学、供应链策略和临床实践的交汇点。製造商和采购商必须在应对不断变化的贸易政策、不同的区域法规和不断演进的临床工作流程的同时，维护患者检体的完整性和可追溯性。策略重点包括投资于赋形剂和密封件的创新，以减少分析前变异性；实现采购来源多元化，以增强应对关税和物流中断的能力；以及加强与终端用户的合作，以确保与自动化分析平台的兼容性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 真空采血管市场依产品类型划分

  • 玻璃
  • 由塑胶製成

9. 真空采血管市场（依采血系统划分）

  • 蝴蝶
  • 注射器
  • 真空管

第十章 添加剂在真空采血管市场的应用

  • 柠檬酸盐
  • EDTA
    • K2 EDTA
    • K3 EDTA
  • 肝素
  • 不含添加剂

第十一章 真空采血管市场（依容量划分）

  • 2 ml
  • 4 ml
  • 6 ml

第十二章 真空采血管市场：依应用领域划分

  • 临床化学
  • 血液学
  • 免疫学
  • 微生物学

第十三章 真空采血管市场（依最终用户划分）

  • 血库
  • 诊断检查室
  • 医院
  • 研究中心

第十四章 各地区真空采血管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 真空采血管市场（依集团划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国真空采血管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章美国真空采血管市场

第十八章 中国真空采血管市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AdvaCare Pharma
  • Becton, Dickinson and Company
  • Biosigma Srl
  • Cardinal Health
  • FL Medical Srl
  • Greiner Bio-One International GmbH
  • Improve Medical Technology Co., Ltd.
  • KABE LABORTECHNIK GmbH
  • Narang Medical Limited
  • Nipro Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13AC2

The Vacutainer Blood Collection Tube Market was valued at USD 1.64 billion in 2025 and is projected to grow to USD 1.74 billion in 2026, with a CAGR of 6.75%, reaching USD 2.60 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.64 billion
Estimated Year [2026] USD 1.74 billion
Forecast Year [2032] USD 2.60 billion
CAGR (%) 6.75%

Strategic executive overview capturing fundamental drivers, clinical implications, material innovations, and procurement considerations shaping the vacutainer sector

This executive summary presents a concise, expert perspective on the vacutainer blood collection tube landscape intended for procurement leaders, clinical laboratory directors, manufacturing strategists, and investors. It synthesizes market dynamics, material and design trends, supply chain sensitivities, and clinical adoption drivers while preserving actionable clarity for decision makers. The narrative emphasizes material selection, system ergonomics, additive compatibility, and end-user workflows as core vectors that shape procurement and product development choices.

Across clinical settings, the vacutainer remains a foundational consumable that connects preanalytics to downstream diagnostic accuracy. Recent developments in polymer science, single-use ergonomics, and additive standardization have elevated product differentiation while regulatory scrutiny on contamination control and traceability has intensified. This introduction frames the subsequent sections by establishing the underlying forces-innovation, regulation, and procurement economics-that will determine near-term strategic priorities for manufacturers, distributors, and large institutional buyers.

Identifying the key transformative shifts redefining product design, supply chain resilience, additive standardization, and clinical workflow implications across the vacutainer market

The vacutainer ecosystem is undergoing several transformative shifts that are altering product design, sourcing strategies, and clinical practice. Materials innovation is a central axis: the migration between glass and advanced plastics reflects competing priorities of sample integrity, breakage risk, and cost efficiency. At the same time, improvements in vacuum sealing technology and tube closure systems have reduced hemolysis rates and enhanced sample stability for sensitive assays, which in turn affects clinician and laboratory preferences.

Supply chain architecture is shifting toward resilience and regionalization as procurement teams seek to mitigate single-source dependencies and transportation disruptions. Parallel to this, additive formulations and standardization efforts are realigning laboratory workflows; the prominence of anticoagulants such as EDTA in its different salt forms and the use of heparin or citrate are driving compatibility requirements across analytical platforms. Clinical practice changes, including point-of-care testing and decentralized sample collection, are also influencing demand profiles for volumes and device ergonomics. Together, these shifts require manufacturers and buyers to balance innovation with operational reliability and regulatory compliance.

Analyzing the cumulative impact of United States tariff adjustments in 2025 on sourcing strategies, production footprints, procurement behavior, and supply chain resilience for vacutainer products

The introduction of tariff adjustments in the United States in 2025 has complex, multi-faceted implications for stakeholders across the vacutainer supply chain. Tariff changes tend to increase landed costs for imported raw materials and finished goods, prompting procurement teams to reassess total cost of ownership and to explore alternative sourcing strategies. When import duties affect glass components, polymer resins, or ancillary packaging, manufacturers may alter production footprints or renegotiate supplier contracts to preserve competitiveness while maintaining quality standards.

Beyond direct cost effects, tariffs influence inventory management and contractual relationships; buyers often expand safety stock and diversify supplier bases to insulate operations from sudden policy shifts, and manufacturers may accelerate nearshoring or partner with regional contract manufacturers to retain market access. Regulatory compliance and customs procedures can introduce additional administrative overhead, elongating lead times and complicating just-in-time replenishment philosophies. Finally, tariffs can serve as a catalyst for innovation in product design and materials substitution as firms pursue lower-tariff inputs or locally sourced alternatives to maintain margin and service levels.

Comprehensive segmentation insights revealing how product type, collection system, additive chemistry, clinical application, end-user needs, and tube volume shape demand and procurement decisions

A granular segmentation analysis reveals nuanced demand drivers across product type, collection system, additive, application, end user, and volume that inform product strategy and go-to-market approaches. In terms of product type, glass continues to be preferred where chemical inertness and high-temperature sterility are prioritized, while plastic variants gain traction for their breakage resistance, weight advantages, and manufacturing scalability. Regarding collection systems, butterfly devices remain important for difficult draws and pediatric care, syringes serve specific bedside or interventional contexts, and vacuum tubes dominate routine laboratory workflows due to their efficiency and compatibility with automated processing.

Additives represent a critical axis of differentiation: citrate supports coagulation testing, EDTA-available as K2 and K3 salts-remains the workhorse for hematology due to its anticoagulant properties, heparin is chosen for specific chemistry panels, and no-additive tubes are deployed when serum separation is required. Application segmentation underscores distinct requirements for clinical chemistry, hematology, immunology, and microbiology, each imposing particular constraints on tube material, additive selection, and sample stability. End-user patterns reveal that blood banks demand high volume and traceability, diagnostic laboratories prioritize automation compatibility, hospitals require versatility across inpatient workflows, and research centers often seek specialized formulations. Volume preferences-commonly 2 ml, 4 ml, and 6 ml-map to specific testing panels, pediatric versus adult sampling, and instrument throughput considerations, shaping SKU portfolios and inventory strategies.

Key regional insights exploring how the Americas, Europe Middle East & Africa, and Asia-Pacific influence manufacturing choices, regulatory alignment, and distribution strategies for vacutainer products

Regional dynamics play a decisive role in shaping manufacturing footprints, regulatory pathways, and distribution strategies for vacutainer products. In the Americas, demand is influenced by large integrated healthcare networks, robust blood banking infrastructures, and advanced clinical laboratory automation, prompting suppliers to focus on scale, documentation, and service agreements. Europe, Middle East & Africa exhibits heterogeneity: stringent regulatory regimes and an emphasis on traceability in parts of Europe drive compliance investments, while markets across the Middle East and Africa prioritize reliability and cost-effective supply amid variable logistics capacities.

Asia-Pacific serves as both a production hub and a rapidly expanding consumption market, driven by growing clinical testing volumes, investments in hospital networks, and regional manufacturing capabilities that lower lead times for neighboring markets. Across regions, regulatory alignment, reimbursement practices, and public health priorities shape procurement cycles and specification requirements. Strategic regional sourcing, localized validation studies, and investments in third-party quality audits can materially improve service levels and reduce time to market for regionally tailored SKUs.

Key corporate and competitive insights outlining how innovation, manufacturing footprint, regulatory rigor, and strategic partnerships differentiate leaders and challengers in the vacutainer market

The competitive landscape is characterized by a mix of established manufacturers, specialized niche producers, and contract manufacturers that collectively drive innovation, scale, and distribution reach. Market leaders tend to differentiate through investments in materials science, high-throughput manufacturing, and robust quality systems that support global regulatory submissions. Specialist firms often compete on targeted innovation-such as low-hemolysis closures, additive optimization for novel assays, or ergonomically designed collection systems-that appeal to specific clinical segments or high-value end users.

Partnerships and strategic alliances between manufacturers and laboratory systems providers accelerate product validation and adoption by ensuring compatibility with automation platforms and assay workflows. At the same time, contract manufacturers and regional players provide flexibility for rapid scale-up and localized production, which helps buyers reduce lead times and comply with regional sourcing preferences. Across the competitive spectrum, compliance with good manufacturing practices, inspection readiness, and robust supply continuity plans remain differentiators that inform purchasing decisions by large laboratories, hospital networks, and public health institutions.

Actionable strategic recommendations for manufacturers, distributors, and purchasers to strengthen innovation pipelines, diversify sourcing, and enhance clinical and commercial alignment

Industry leaders should pursue a multi-pronged strategy that balances material innovation, supply chain resilience, and close alignment with clinical workflows to capture durable competitive advantage. Prioritize material and additive R&D that demonstrably improves sample integrity and reduces preanalytic variability, while validating those improvements across common clinical applications such as clinical chemistry and hematology. Simultaneously, diversify manufacturing and sourcing to include regional partners that can mitigate tariff-related exposure and shorten replenishment cycles under changing trade conditions.

Invest in stronger collaboration with end users-blood banks, diagnostic laboratories, hospitals, and research centers-to co-develop SKUs optimized for automation compatibility, volume demands, and clinical protocols. Strengthen regulatory and quality infrastructures to streamline cross-border approvals and to support rapid product iterations. Finally, use data from post-market surveillance and laboratory feedback loops to refine product specifications and to create compelling value propositions that demonstrate lower total cost of handling, improved sample integrity, and reduced clinical retests.

Transparent and rigorous research methodology overview describing primary stakeholder engagement, secondary validation, data triangulation, and quality control measures applied to the analysis

The analysis draws on a blended research approach that combines primary interviews with laboratory directors, procurement leads, manufacturing engineers, and clinical scientists together with comprehensive secondary validation from regulatory documents, manufacturing standards, and product literature. Primary research included structured interviews and targeted workshops to surface procurement pain points, additive preferences, and automation compatibility issues. Secondary sources were used to validate regulatory pathways, materials performance claims, and publicly available manufacturing practice guidance.

Data triangulation techniques were applied to reconcile qualitative insights with operational metrics and documented product specifications. Quality controls included cross-validation of interview findings across multiple stakeholder groups, versioned documentation of assumptions, and expert peer review to ensure analytical rigor. The methodology emphasized transparency in segmentation definitions and avoided reliance on any single source, ensuring that conclusions reflect a robust synthesis of operational realities and clinical needs.

Concluding synthesis of strategic imperatives that harmonize material innovation, supply chain agility, regulatory readiness, and end-user collaboration in the vacutainer domain

In conclusion, the vacutainer blood collection tube ecosystem sits at the intersection of materials science, supply chain strategy, and clinical practice evolution. Manufacturers and buyers must navigate trade policy shifts, regional regulatory diversity, and changing clinical workflows while preserving the integrity and traceability of patient samples. Strategic priorities include investing in additive and closure innovations that reduce preanalytic variability, diversifying sourcing to improve resilience against tariff and logistics disruptions, and deepening collaboration with end users to ensure compatibility with automated analytical platforms.

Looking forward, organizations that combine technical excellence in tube design with agile manufacturing footprints and strong regulatory capabilities will be best positioned to support evolving clinical workflows and procurement expectations. By focusing on validated performance gains, responsive supply chain models, and targeted engagement with high-value end users, stakeholders can convert uncertainty into opportunities for differentiation and sustained operational reliability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vacutainer Blood Collection Tube Market, by Product Type

  • 8.1. Glass
  • 8.2. Plastic

9. Vacutainer Blood Collection Tube Market, by Blood Collection System

  • 9.1. Butterfly
  • 9.2. Syringe
  • 9.3. Vacuum Tube

10. Vacutainer Blood Collection Tube Market, by Additive

  • 10.1. Citrate
  • 10.2. Edta
    • 10.2.1. K2 Edta
    • 10.2.2. K3 Edta
  • 10.3. Heparin
  • 10.4. No Additive

11. Vacutainer Blood Collection Tube Market, by Volume

  • 11.1. 2 Ml
  • 11.2. 4 Ml
  • 11.3. 6 Ml

12. Vacutainer Blood Collection Tube Market, by Application

  • 12.1. Clinical Chemistry
  • 12.2. Hematology
  • 12.3. Immunology
  • 12.4. Microbiology

13. Vacutainer Blood Collection Tube Market, by End User

  • 13.1. Blood Banks
  • 13.2. Diagnostic Laboratories
  • 13.3. Hospitals
  • 13.4. Research Centers

14. Vacutainer Blood Collection Tube Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Vacutainer Blood Collection Tube Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Vacutainer Blood Collection Tube Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Vacutainer Blood Collection Tube Market

18. China Vacutainer Blood Collection Tube Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdvaCare Pharma
  • 19.6. Becton, Dickinson and Company
  • 19.7. Biosigma S.r.l.
  • 19.8. Cardinal Health
  • 19.9. F.L. Medical S.r.l.
  • 19.10. Greiner Bio-One International GmbH
  • 19.11. Improve Medical Technology Co., Ltd.
  • 19.12. KABE LABORTECHNIK GmbH
  • 19.13. Narang Medical Limited
  • 19.14. Nipro Corporation
  • 19.15. QIAGEN N.V.
  • 19.16. Sarstedt AG & Co. KG
  • 19.17. Sekisui Medical Co., Ltd.
  • 19.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 19.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BUTTERFLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VACUUM TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K2 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY K3 EDTA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY NO ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 2 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 4 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY 6 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 152. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 154. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 155. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 178. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 179. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 184. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 186. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 187. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. NATO VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY BLOOD COLLECTION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY ADDITIVE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY EDTA, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY VOLUME, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA VACUTAINER BLOOD COLLECTION TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)